- Home
- DIT vs MURA Comparison
DIT vs MURA Comparison
Compare DIT & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- MURA
- Stock Information
- Founded
- DIT 1981
- MURA 2013
- Country
- DIT United States
- MURA Ireland
- Employees
- DIT N/A
- MURA N/A
- Industry
- DIT Food Distributors
- MURA
- Sector
- DIT Consumer Discretionary
- MURA
- Exchange
- DIT Nasdaq
- MURA Nasdaq
- Market Cap
- DIT 78.7M
- MURA 67.2M
- IPO Year
- DIT 1995
- MURA N/A
- Fundamental
- Price
- DIT $119.00
- MURA $1.18
- Analyst Decision
- DIT
- MURA Strong Buy
- Analyst Count
- DIT 0
- MURA 5
- Target Price
- DIT N/A
- MURA $13.00
- AVG Volume (30 Days)
- DIT 222.0
- MURA 417.8K
- Earning Date
- DIT 04-17-2025
- MURA 03-11-2025
- Dividend Yield
- DIT 0.84%
- MURA N/A
- EPS Growth
- DIT N/A
- MURA N/A
- EPS
- DIT 5.93
- MURA N/A
- Revenue
- DIT $2,202,495,291.00
- MURA N/A
- Revenue This Year
- DIT N/A
- MURA $79.64
- Revenue Next Year
- DIT N/A
- MURA N/A
- P/E Ratio
- DIT $20.05
- MURA N/A
- Revenue Growth
- DIT 7.62
- MURA N/A
- 52 Week Low
- DIT $115.37
- MURA $1.12
- 52 Week High
- DIT $187.00
- MURA $5.02
- Technical
- Relative Strength Index (RSI)
- DIT 41.56
- MURA 17.03
- Support Level
- DIT $115.37
- MURA $3.77
- Resistance Level
- DIT $125.48
- MURA $4.35
- Average True Range (ATR)
- DIT 2.75
- MURA 0.27
- MACD
- DIT -0.88
- MURA -0.31
- Stochastic Oscillator
- DIT 24.80
- MURA 1.86
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.